About
Dr. Swain has served on the board of Seagen since November 2022. With over thirty years of experience in clinical trial design, implementation, execution and publication of major international trials in breast cancer, she brings a critical perspective to our development of targeted oncology therapies.
Dr. Swain is the Associate Dean for Research Development and Professor of Medicine at the Georgetown University Medical Center and the Vice President of Genetic Medicine for MedStar Health. Previously, she held leadership roles at the National Cancer Institute (NCI), National Institutes of Health (NIH) and the Washington Cancer Institute at MedStar Washington Hospital Center. Dr. Swain is a fellow of the American College of Physicians and the American Society of Clinical Oncology (ASCO). She has served on ASCO’s board of directors and is a past president (2012-2013). She currently serves on the Conquer Cancer Foundation Board of ASCO and chairs the Women Who Conquer Cancer committee. Dr. Swain has also published over 325 articles, including many regarding clinical trials in breast cancer.
Dr. Swain holds an M.D. from the University of Florida and a B.A. in Chemistry from the University of North Carolina. She completed her fellowship in medical oncology at the NCI, NIH.
Personal Details
Qualifications & Experience
Other directorships (state)
(only entities turnover at least $5m p/a)
| Company | Committee | Position | Date Appointed |
|---|---|---|---|
 | Board | Member | 01/01/2013 |
Working history
Committee/s
| Company | Committee | Role | Appointment Date | Resignation Date |
|---|---|---|---|---|
| Seattle Genetics | Board | Member | 01/11/2022 | |
| Seattle Genetics | Nominations & Governance | Member | 01/11/2022 |